Allergy Immunotherapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Allergy Immunotherapy Market: By Treatment Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Specific Immunotherapy (SIT)), By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global allergy immunotherapy market is expected to be valued at US$ 1,949.2 Mn in 2020 and growing at a CAGR of 9.4% over the forecast period to reach US$ 3,381.7 Mn by 2027 owing to growing occurrence of sensitivities such as allergies and ineffective treatment procedures, such as pharmacotherapy, to control the prevalence rate of allergies are the major factors boosting the adoption of allergy immunotherapy Market, which is considered as a designated treatment for various types of allergies. Increasing death rates due to allergies is the main reason due to which government is supporting to invest in research and development to provide the better and improved treatment options for the patients. Allergy immunotherapy is a treatment that prevents allergic reactions from a variety of sources, including food, grass pollen, dust, and bee venom. Allergy immunotherapy helps people with allergies such as rhinitis, asthma, and conjunctivitis, among other allergies, regulate their symptoms. Allergy immunotherapy is regular injections that gradually increase the dosage in order to create resistance in the patient. Because of the increased creation of blocking antibodies that combat the foreign chemicals that cause allergies, the patient’s immunity system becomes less brittle when the dosage is gradually increased.

Allergy Immunotherapy Market

MARKET SUMMARY
-
9.4%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 9.4%
  • Largest Market– Europe
  • Fastest Growing Market– Asia-Pacific

Allergy Immunotherapy Market

  • Global allergy immunotherapy market report gives comprehensive outlook on allergy immunotherapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global allergy immunotherapy market gives historical, current, and future market sizes (US$ Mn) on the basis of treatment type, allergy type, distribution channel, and region.
  • This report studies global allergy immunotherapy market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global allergy immunotherapy products.
Market Key Players
  • Stallergenes Greer
  • ALK
  • Allergy Therapeutics
  • Merck KGaA
  • HAL Allergy B.V.
  • Biomay AG
  • Anergis
Growth

Allergy Immunotherapy Market

The prevalence of allergic patients are being increasing every year. According to the WAO (World Allergy Organization), a prominent growth in the ubiquity of allergies has been observed in the recent past. More than 30% of the total global population are suffering from allergic rhinitis. According to Health Statistics, around 8% of the U.S. adults suffer from sinusitis and hay fever. To create awareness among the population on allergies, number of government organizations came forward to support the program to create awareness among the population regarding the benefits of the allergy immunotherapy.


Europe got significant share

Allergy Immunotherapy Market

Europe is expected to grow with highest CAGR over the forecast years owing to surge in awareness among the population and accessibility of number of allergic immunotherapy treatment options coupled with increasing investments in development of novel drugs and therapy procedures for the allergic treatments are anticipated to drive the growth of the market. Moreover, increasing number of products in clinical trials and rising number patients in the region are fueling the growth of the market. Asia Pacific and Latin America are expected to grow with significant CAGR over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Developments

  • In January 2019, Sandoz Inc., has announced the U.S. market introduction of SYMJEP (epinephrine) 0.3 mg injection for the emergency treatment of allergic reactions (Type 1)
  • In June 2018, Aimmune Therapeutics, declared phase 3 trial results for AR101, an oral immunotherapy medication focused on peanut allergies, have met all the end points required by the U.S. Food and Drug Administration (FDA)

Key

Key Findings of the Report


Key

Key features of the report

Allergy Immunotherapy Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Stallergenes Greer
  • ALK
  • Allergy Therapeutics
  • Merck KGaA
  • HAL Allergy B.V.
  • Biomay AG
  • Anergis
  • Aimmune Therapeutics
  • Circassia
  • DBV Technologies

Description

The global allergy immunotherapy market is expected to be valued at US$ 1,949.2 Mn in 2020 and growing at a CAGR of 9.4% over the forecast period to reach US$ 3,381.7 Mn by 2027 owing to growing occurrence of sensitivities such as allergies and ineffective treatment procedures, such as pharmacotherapy, to control the prevalence rate of allergies are the major factors boosting the adoption of allergy immunotherapy Market, which is considered as a designated treatment for various types of allergies. Increasing death rates due to allergies is the main reason due to which government is supporting to invest in research and development to provide the better and improved treatment options for the patients. Allergy immunotherapy is a treatment that prevents allergic reactions from a variety of sources, including food, grass pollen, dust, and bee venom. Allergy immunotherapy helps people with allergies such as rhinitis, asthma, and conjunctivitis, among other allergies, regulate their symptoms. Allergy immunotherapy is regular injections that gradually increase the dosage in order to create resistance in the patient. Because of the increased creation of blocking antibodies that combat the foreign chemicals that cause allergies, the patient’s immunity system becomes less brittle when the dosage is gradually increased.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX